Note: Ingredients listed on restricted chemical lists
EC/CAS
232-268-1/8000-41-7
Name of the chemical
2-(4-methylcyclohex-3-en-1-yl)propan-2-ol; p-Menth-1-en-8-ol (alpha-Terpineol); 1-methyl-4-(1-methylvinyl)cyclohexan-1-ol (beta-Terpineol); 1-methyl-4-(1-methylethylidene)cyclohexan-1-ol (gamma-Terpineol) (40)
Concentration
6.5 - 13
EC/CAS
205-341-0/5989-27-5
Name of the chemical
(R)-p-mentha-1,8-diene
Concentration
3.5 - 7
EC/CAS
204-262-9/118-58-1
Name of the chemical
Benzyl salicylate
Concentration
0.5 - 1
EC/CAS
202-589-1/97-53-0
Name of the chemical
eugenol
Concentration
0.3 - 0.5
EC/CAS
203-909-2/111-80-8
Name of the chemical
Methyl octine carbonate; Methyl non-2-ynoate
Concentration
0.1 - 0.1
EC/CAS
203-956-9/112-30-1
Name of the chemical
1-decanol
Concentration
0 - 0.0029
EC/CAS
266-803-5
Name of the chemical
Allyl isoamyloxyacetate
Concentration
0.3 - 0.6
General Information
Version
2.0
Revision date
2023-10-16
Product name
WHITE LILAC
1.2.1 Relevant identified uses
Industrial use,Professional use Industrial/Professional use spec
Icons in SDS
Company Information
company name
according to the REACH Regulation (EC)
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H412
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage. Toxic to aquatic life with long lasting effects. Harmful to aquatic life with long lasting effects
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Contains
d-Limonene; Hexyl salicylate; Phenylethyl acetate; Nopyl acetate; Hexyl cinnamic aldehyde; Triplal (Vertocitral); Benzyl salicylate; Eugenol; Phenylacetaldehyde; Methyl octine carbonate
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P302+P352 - IF ON SKIN: Wash with plenty of water.
Additional information
For professional users only.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 1 H318 Skin sensitisation, Category 1 H317 Hazardous to the aquatic environment – Chronic Hazard, Category 3 H412 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage. Toxic to aquatic life with long lasting effects. Harmful to aquatic life with long lasting effects. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS05 GHS07 Signal word (CLP) : Danger Contains : d-Limonene; Hexyl salicylate; Phenylethyl acetate; Nopyl acetate; Hexyl cinnamic aldehyde; Triplal (Vertocitral); Benzyl salicylate; Eugenol; Phenylacetaldehyde; Methyl octine carbonate Hazard statements (CLP) : H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H412 - Harmful to aquatic life with long lasting effects. Precautionary statements (CLP) : P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P302+P352 - IF ON SKIN: Wash with plenty of water. Extra phrases : For professional users only. 2.3. Other hazards Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Terpineol CAS-No.: 8000-41-7 6.5 – 13 Skin Irrit. 2, H315 EC-No.: 232-268-1 Eye Irrit. 2, H319 (R)-p-mentha-1,8-diene; d-limonene CAS-No.: 5989-27-5 3.5 – 7 Flam. Liq. 3, H226 substance with national workplace exposure limit(s) EC-No.: 205-341-0 Skin Irrit. 2, H315 (DE, ES, FI, SI, NO, CH) EC Index-No.: 601-096-00-2 Skin Sens. 1B, H317 REACH-no: 01-2119493353- Asp. Tox. 1, H304 35 Aquatic Acute 1, H400 Aquatic Chronic 3, H412 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed CAS-No.: 63500-71-0 1 – 4.007 Eye Irrit. 2, H319 isomers (cis and trans) EC-No.: 405-040-6 EC Index-No.: 603-101-00-3 REACH-no: 01-000015458-64 Benzyl acetate CAS-No.: 140-11-4 2 – 4 Aquatic Chronic 3, H412 substance with national workplace exposure limit(s) EC-No.: 205-399-7 (BE, DK, ES, IE, LT, LV, PT, RO) REACH-no: 01-2119638272- 42 Phenylethyl acetate CAS-No.: 103-45-7 1.5 – 3 Eye Dam. 1, H318 EC-No.: 203-113-5 REACH-no: 01-2119976340- 38 Nopyl acetate CAS-No.: 128-51-8 1.5 – 3 Eye Irrit. 2, H319 EC-No.: 204-891-9 Aquatic Chronic 2, H411 Skin Sens. 1B, H317 Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Hexyl cinnamic aldehyde CAS-No.: 101-86-0 1.5 – 3 Skin Sens. 1, H317 EC-No.: 202-983-3 Aquatic Chronic 2, H411 REACH-no: 01-2119533092- 50 Dihydromyrcenol CAS-No.: 18479-58-8 1.3 – 2.5 Skin Irrit. 2, H315 EC-No.: 242-362-4 Eye Irrit. 2, H319 REACH-no: 01-2119457274- 37 Triplal (Vertocitral) CAS-No.: 68039-49-6 1 – 2.0355 Skin Irrit. 2, H315 EC-No.: 268-264-1 Eye Irrit. 2, H319 Skin Sens. 1, H317 Aquatic Chronic 3, H412 Verdyl acetate CAS-No.: 5413-60-5 0.8 – 1.5 Aquatic Chronic 3, H412 EC-No.: 226-501-6 Benzyl salicylate CAS-No.: 118-58-1 0.5 – 1 Eye Irrit. 2, H319 EC-No.: 204-262-9 Skin Sens. 1B, H317 EC Index-No.: 607-754-00-5 Aquatic Chronic 3, H412 REACH-no: 01-2119969442- 31 Rose crystals CAS-No.: 90-17-5 0.5 – 1 Skin Irrit. 2, H315 EC-No.: 201-972-0 Aquatic Chronic 3, H412 Allyl amyl glycolate CAS-No.: 67634-00-8 0.3 – 0.6 Acute Tox. 4 (Oral), H302 EC-No.: 266-803-5 Acute Tox. 2 (Inhalation), H330 Aquatic Chronic 1, H410 para-Cresyl methyl ether CAS-No.: 104-93-8 0.3 – 0.5 Acute Tox. 4 (Oral), H302 EC-No.: 203-253-7 Repr. 2, H361 Skin Irrit. 2, H315 Eugenol CAS-No.: 97-53-0 0.3 – 0.5 Acute Tox. 4 (Oral), H302 EC-No.: 202-589-1 Eye Irrit. 2, H319 REACH-no: 01-2119971802- Skin Sens. 1B, H317 33 Hexyl salicylate CAS-No.: 6259-76-3 0.02 – 0.4 Skin Irrit. 2, H315 EC-No.: 228-408-6 Skin Sens. 1, H317 Aquatic Acute 1, H400 Aquatic Chronic 1, H410 isopentyl acetate CAS-No.: 123-92-2 0.1 – 0.1 Flam. Liq. 3, H226 substance with national workplace exposure limit(s) EC-No.: 204-662-3 (AT, BE, BG, CY, DE, DK, EE, ES, FI, FR, GI, GR, EC Index-No.: 607-130-00-2 HR, HU, IE, IT, LT, LU, LV, MT, NL, PL, PT, RO, SE, REACH-no: 01-2119548408- SI, SK, NO, TR); substance with a Community 32 workplace exposure limit Phenylacetaldehyde CAS-No.: 122-78-1 0.1 – 0.1 Acute Tox. 4 (Oral), H302 EC-No.: 204-574-5 Skin Corr. 1B, H314 REACH-no: 01-2120766865- Eye Dam. 1, H318 37 Skin Sens. 1B, H317 Aquatic Chronic 3, H412 Methyl octine carbonate CAS-No.: 111-80-8 0.1 – 0.1 Acute Tox. 4 (Oral), H302 EC-No.: 203-909-2 Skin Sens. 1, H317 REACH-no: 01-2120139912- 55 Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Alcohol C-10 CAS-No.: 112-30-1 0 – 0.0029 Aquatic Chronic 3, H412 substance with national workplace exposure limit(s) EC-No.: 203-956-9 (BG, DE, LT, LV, RO, CH) Aldehyde C-6 CAS-No.: 66-25-1 0 – 0.0007 Flam. Liq. 3, H226 substance with national workplace exposure limit(s) EC-No.: 200-624-5 (FI, PL) Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures general : Never give anything by mouth to an unconscious person. If you feel unwell, seek medical advice (show the label where possible). First-aid measures after inhalation : Remove person to fresh air and keep comfortable for breathing. Allow the victim to rest. First-aid measures after skin contact : If skin irritation occurs: Get medical advice/attention. Wash skin with plenty of water. Take off contaminated clothing. If skin irritation or rash occurs: Get medical advice/attention. First-aid measures after eye contact : Obtain medical attention if pain, blinking or redness persists. Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call a physician immediately. First-aid measures after ingestion : Obtain emergency medical attention. Call a poison center or a doctor if you feel unwell. 4.2. Most important symptoms and effects, both acute and delayed Symptoms/effects : Not expected to present a significant hazard under anticipated conditions of normal use. Symptoms/effects after skin contact : Irritation. May cause an allergic skin reaction. Symptoms/effects after eye contact : Serious damage to eyes. 4.3. Indication of any immediate medical attention and special treatment needed Treat symptomatically. SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media : Sand. Water spray. Dry powder. Foam. Carbon dioxide. Unsuitable extinguishing media : Do not use a heavy water stream. 5.2. Special hazards arising from the substance or mixture Hazardous decomposition products in case of fire : Toxic fumes may be released. 5.3. Advice for firefighters Firefighting instructions : Use water spray or fog for cooling exposed containers. Exercise caution when fighting any chemical fire. Prevent fire fighting water from entering the environment. Protection during firefighting : Do not enter fire area without proper protective equipment, including respiratory protection. Do not attempt to take action without suitable protective equipment. Self-contained breathing apparatus. Complete protective clothing. SECTION 6: Accidental release measures 6.1. Personal precautions, protective equipment and emergency procedures 6.1.1. For non-emergency personnel Emergency procedures : Ventilate spillage area. Evacuate unnecessary personnel. Avoid contact with skin and eyes. Avoid breathing dust/fume/gas/mist/vapours/spray. 6.1.2. For emergency responders Protective equipment : Do not attempt to take action without suitable protective equipment. Equip cleanup crew with proper protection. For further information refer to section 8: "Exposure controls/personal protection". Emergency procedures : Ventilate area. 6.2. Environmental precautions Avoid release to the environment. Notify authorities if liquid enters sewers or public waters. 6.3. Methods and material for containment and cleaning up